001452043 000__ 05589cam\a2200505\i\4500
001452043 001__ 1452043
001452043 003__ OCoLC
001452043 005__ 20230310003338.0
001452043 006__ m\\\\\o\\d\\\\\\\\
001452043 007__ cr\cn\nnnunnun
001452043 008__ 230113s2022\\\\sz\a\\\\o\\\\\001\0\eng\d
001452043 019__ $$a1357018092
001452043 020__ $$a9783031082504$$q(electronic bk.)
001452043 020__ $$a3031082508$$q(electronic bk.)
001452043 020__ $$z9783031082498
001452043 020__ $$z3031082494
001452043 0247_ $$a10.1007/978-3-031-08250-4$$2doi
001452043 035__ $$aSP(OCoLC)1356890830
001452043 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCQ$$dUKAHL
001452043 049__ $$aISEA
001452043 050_4 $$aRC280.E9
001452043 08204 $$a616.99/484$$223/eng/20230113
001452043 24500 $$aGlobal perspectives in ocular oncology /$$cBhavna V. Chawla, Mary E. Aronow, editors.
001452043 264_1 $$aCham :$$bSpringer,$$c[2022]
001452043 264_4 $$c©2022
001452043 300__ $$a1 online resource (xxii, 426 pages) :$$billustrations (chiefly color)
001452043 336__ $$atext$$btxt$$2rdacontent
001452043 337__ $$acomputer$$bc$$2rdamedia
001452043 338__ $$aonline resource$$bcr$$2rdacarrier
001452043 500__ $$aIncludes index.
001452043 5050_ $$aWorking Together: Specialty Interest Groups with Global Presence -- Working Together: Specialty Interest Groups with Global Presence -- Worldwide Analysis: The Global Presentation of Retinoblastoma -- International Collaborations for Characterizing Ocular Adnexal Lymphoma -- The IRIS (Intelligent Research in Sight) Registry in Ocular Oncology -- Intravenous Chemotherapy for Retinoblastoma: A Pediatric Oncologists Perspective -- INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: A Team Effort -- Treatment Algorithms for Intraocular Retinoblastoma: An Ocular Oncologists Perspective -- Treatment for Primary Vitreoretinal Lymphoma: The Neuro-Oncologists View -- Treatment for Primary Vitreoretinal Lymphoma: The Neuro-Oncologists View -- Systemic and Genetic Associations of Ocular & Ocular Adnexal Neoplasms -- A Singular View: The Ocularists Role in Eye Loss Restoration and Rehabilitation -- Guidelines and Recommendations for Retinoblastoma Screening -- Orbital and Metastatic Retinoblastoma: Conquests and Challenges -- Metastatic Behavior of Uveal Melanoma: From Biology to Treatment -- Intra-vitreal Chemotherapy for Vitreoretinal Lymphoma -- Update on Uveal Lymphoma -- Topical Chemotherapy for Ocular Surface Squamous Neoplasia -- Surgical Management of Ocular Surface Squamous Neoplasia -- Genomics: Past, Present and Future -- Application of Deep Learning Models in the Evaluation of Histopathology of Uveal Melanoma -- Developing Prognostic Tools for Estimating Risk of Metastatic Death and Non-Metastatic Death in Individuals with Choroidal Melanoma -- Applications of Plaque Brachytherapy in Anterior Segment Ocular Tumors: A Clinical Review -- The Role of Telemedicine in Ocular Oncology -- Harnessing the Power of Artificial Intelligence -- Developing Animal Models in Ocular Oncology -- Iris Melanoma: Advanced Surgical Techniques -- The MOLES Acronym and Scoring System for Estimating Likelihood of Malignancy in Melanocytic Choroidal Tumors -- Novel Therapies for Choroidal Melanoma -- Novel Treatment Strategies for Malignant Anterior Segment Tumors -- Recent Developments in the Management of Orbital and Periocular Neoplasms -- Recent Developments in the Management of Orbital and Periocular Neoplasms -- The Rise in Immunotherapy and Associated Ocular Toxicities -- Awareness, Advocacy, and the Volunteer Sector -- Overcoming Challenges in the Delivery of Care: The Thailand Story -- Building a Retinoblastoma Service in China -- Retinoblastoma, the African Context -- The Brazilian Experience: The Retinoblastoma Awareness Campaign -- The Brazilian Experience: The Retinoblastoma Awareness Campaign -- Ocular Oncology Practice during the COVID-19 Pandemic -- Pearls from a mentor and legend in ophthalmic pathology and oncology.
001452043 506__ $$aAccess limited to authorized users.
001452043 520__ $$aEye cancers vary in presentation depending upon geographic location and access to healthcare. Global Perspectives in Ocular Oncology offers an international platform for leading ocular oncologists and multidisciplinary specialists to highlight worldwide strengths and solutions to the challenges in treating eye cancer. The goal of the book is to provide a universal view on the management of adult and pediatric tumors affecting the eye and ocular adnexa. A range of topics pertinent to the global community have been included. Organized into seven distinct sections, this book covers international collaborations and initiatives, technology and innovations, and novel treatment strategies. In addition, it provides a glimpse into the future of the specialty. The emphasis on sharing perspectives as well as the global and multidisciplinary framework of the book are unique to the market. This work will appeal to a variety of audiences including ocular oncologists and ophthalmic subspecialists, oncologists and other specialists, optometrists, geneticists, allied medical professionals, and trainees entering these disciplines.
001452043 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 13, 2023).
001452043 650_0 $$aEye$$xCancer.
001452043 655_0 $$aElectronic books.
001452043 7001_ $$aChawla, Bhavna V.,$$eeditor.
001452043 7001_ $$aAronow, Mary E.,$$eeditor.
001452043 77608 $$iPrint version: $$z3031082494$$z9783031082498$$w(OCoLC)1317837207
001452043 852__ $$bebk
001452043 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-08250-4$$zOnline Access$$91397441.1
001452043 909CO $$ooai:library.usi.edu:1452043$$pGLOBAL_SET
001452043 980__ $$aBIB
001452043 980__ $$aEBOOK
001452043 982__ $$aEbook
001452043 983__ $$aOnline
001452043 994__ $$a92$$bISE